Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket

BenzingaNov 19 19:30

Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders

BenzingaNov 18 23:06

Enveric Biosciences 3Q Loss/Shr 24c >ENVB

Dow JonesNov 15 05:23

Enveric Biosciences | 10-Q: Q3 2024 Earnings Report

SECNov 15 05:17 · Announcements

Express News | Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results

BreakingsNov 15 05:05

Enveric Biosciences Canada Granted U.S. Patent #12138276: Halogenated Psilocybin Derivatives and Methods of Using

BenzingaNov 13 05:22